Applied Therapeutics to Present at the 14th International Congress of Inborn Errors of Metabolism

NEXT STORY
Verrica Pharmaceuticals Announces FDA Acceptance of its IND Application for LTX-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma
PREV STORY
Teleflex Earns Top Spot in MedReps Best Places to Work 2022 Ranking
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Intercept to Report 2016 Full Year Financial Results on February 23 and Present at Upcoming Conferences

NEW YORK, Feb. 17, 2017 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical ...

author_avatar
NASDAQ Market News

Pan-Canadian studies investigate why COVID-19 has been so devastating to long-term care facility residents and staff

author_avatar
NASDAQ Market News

Shire plc : Result of AGM

author_avatar
NASDAQ Market News